the other point to add to Matillas , is that lke don’t own the dle process . Lilac do . There is nothing in this “partnership” that gives them any IP in the technology . If you go through all disclosed information on the partnership between lke and lilac , details of their partnership are very skant or almost non existent . Who gets what share of the benefits if lilac successfully develop their dle technology ?
Now ask yourself this question , if your own a high tech patented process and someone is supplying you a run of the mill raw material that without your process they probably have a very high capex / high opex output instead resulting , you are going to extract a very large premium from them in any formalised jv . Put differently , lilac have all the trump cards .
The other thing to bear in mind even with the lilac process is you end up with lithium chloride which then needs to be further treated to lithium carbonate . So another player again needs to be involved . None of this is meant to be critical of lake but rather pointing out lke is a much higher risk play as they are starting with a significantly lower quality input and as Matilda rightly pointed out hence their desire to go hard on very unproven technology .
- Forums
- ASX - By Stock
- GLN
- Ann: Trading Halt
Ann: Trading Halt, page-113
Featured News
Add GLN (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.20M |
Open | High | Low | Value | Volume |
17.0¢ | 17.5¢ | 16.5¢ | $251.5K | 1.483M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 568075 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 92256 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 568075 | 0.165 |
21 | 1189328 | 0.160 |
7 | 1258080 | 0.155 |
14 | 600550 | 0.150 |
2 | 360000 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 92256 | 3 |
0.175 | 164087 | 3 |
0.180 | 146987 | 6 |
0.185 | 180000 | 3 |
0.190 | 192661 | 5 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
GLN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online